Led by Dr. James Scicolone, will tour the first pioneering full-scale continuous direct compression tablet manufacturing line. This line is spread across a 3-floor equipment train including excipient dispensing, continuous blending, and tablet compression, all monitored by advanced process analytical technology (PAT) for real time content uniformity and near-instant release testing. This facility served as the prototype for Janssen Pharmaceuticals' continuous manufacturing line in Gurabo, Puerto Rico, developed in collaboration with Rutgers. In 2016, the FDA approved this line for producing PREZISTA (darunavir), marking it as J&J’s first commercial product manufactured using continuous processes. The transition to continuous manufacturing, supported by a myriad of pharmaceutical companies and FDA , helps to enhance efficiency, reduce waste, and accelerate time-to-market for medications .
